Alison Ohringer, MD, MPH, MS
Resident Physician
Medicine
School of Medicine

Interests

Show all (1) Hide

• Ehlers-Danlos Syndrome

Publications (10)

Top publication keywords:
AsiaTuberculosis, PulmonaryHand, Foot and Mouth DiseaseStudents, MedicalCaliforniaSpatio-Temporal AnalysisEnterovirus A, HumanHarm ReductionHepatitis CVaccines, InactivatedChinaMedicineEnterovirusPerceptionSubstance Abuse, Intravenous

• Tolerance of Guideline-Directed Medical Therapy-Reply.
  JAMA internal medicine 2025 Ayoola A, Ohringer A, Nguyen OK
• Guideline-Directed Medical Therapy Intolerance in Heart Failure.
  JAMA internal medicine 2024 Ayoola A, Ohringer A, Nguyen OK
• Nothing About Us Without Us: Students' Role in Combating Systemic Inequity in Medicine.
  Academic medicine : journal of the Association of American Medical Colleges 2022 Nwaba AUA, Willey B, Ohringer AR
• Renal Columns.
  JAMA 2021 Levy ZD, Ohringer AR, Haight B
• Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018.
  BMC public health 2021 Ohringer AR, Serota DP, McLean RL, Stockman LJ, Watt JP

Show all (5 more) Hide

• Immunological Treatment Failure Among Adult Patients Receiving Highly Active Antiretroviral Therapy in East Africa: A Systematic Review and Meta-Analysis.
  Current therapeutic research, clinical and experimental 2021 Dessie G, Mulugeta H, Wagnew F, Zegeye A, Kiross D, Negesse A, Aynalem YA, Getaneh T, Ohringer A, Burrowes S
• Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011-2018: A Longitudinal Surveillance Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 Head JR, Collender PA, Lewnard JA, Skaff NK, Li L, Cheng Q, Baker JM, Li C, Chen D, Ohringer A, Liang S, Yang C, Hubbard A, Lopman B, Remais JV
• Nervous Breakdown-and-Across.
  JAMA 2020 Ohringer AR, Haight B
• Prison-based harm reduction services are needed to address the dual substance use disorder and infectious disease epidemics in US prisons.
  EClinicalMedicine 2020 Ohringer AR, Ezer T, Serota DP
• Evidence for heterogeneity in China's progress against pulmonary tuberculosis: uneven reductions in a major center of ongoing transmission, 2005-2017.
  BMC infectious diseases 2019 Li T, Cheng Q, Li C, Stokes E, Collender P, Ohringer A, Li X, Li J, Zelner JL, Liang S, Yang C, Remais JV, He J